Gender | Age | Allopurinol start | Febuxostat start | Rash with febuxostat | Outcome with benzbromarone | ||
---|---|---|---|---|---|---|---|
Dosage | GFR | Dosage | GFR | ||||
(mg/d) | (mL/min) | (mg/d) | (mL/min) | ||||
Female | 70 | 50 | 78 | 120 | 77.2 | Nonspecific | No rash |
Male | 69 | N/A | 90 | 40 | 90.5 | SJS | No rash |
Female | 68 | 100 | 52 | 80 | 80.3 | Nonspecific | No rash |
Male | 45 | 50 | 90 | 80 | 90.9 | Nonspecific | No rash |
Female | 41 | 300 | 40 | 5 | 40.9 | Nonspecific | No rash |
GFR: glomerular filtration rate; SSJ: Stevens-Johnson syndrome.